RCP
MDT icon

Rothschild Capital Partners’s Medtronic MDT Stock Holding History

Rothschild Capital Partners’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,710
Closed -$356K – 104
2025
Q4 		$356K Hold
3,710
– – 0.08% 60
2025
Q3 		$353K Hold
3,710
– – 0.08% 63
2025
Q2 		$323K Hold
3,710
– – 0.08% 60
2025
Q1 		$333K Sell
3,710
-76
-2% -$6.8K 0.09% 61
2024
Q4 		$302K Sell
3,786
-33,933
-90% -$2.94M 0.07% 71
2024
Q3 		$3.4M Buy
37,719
+49
+0.1% +$4.12K 0.95% 28
2024
Q2 		$2.97M Hold
37,670
– – 0.85% 26
2024
Q1 		$3.28M Buy
+37,670
New +$3.21M 0.95% 27

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Rothschild Capital Partners's MDT Position: Q1 2026 in Review

Rothschild Capital Partners sold out of Medtronic (MDT) in Q1 2026, closing a stake of 3,710 shares — an estimated $356K sold.

Rothschild Capital Partners first reported a position in MDT in Q1 2024 and held it in 8 quarters. The position peaked at $3.4M in Q3 2024. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Rothschild Capital Partners reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
  • Rothschild Capital Partners sold 3,710 Medtronic shares in Q1 2026, an estimated $356K.
  • Rothschild Capital Partners first reported a position in Medtronic in Q1 2024 and held it in 8 quarters.
  • Rothschild Capital Partners's Medtronic position peaked at $3.4M in Q3 2024.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Rothschild Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.